Prolotherapy injects a 12.5 to 25% dextrose solution, not stem cells, into weak ligaments and tendons over 3 to 6 sessions. What to expect before, during and after, the evidence, and how it compares with PRP, cortisone and stem cell therapy.
At a Glance Multiple clinical trials (including from Stanford University) show LDN can reduce fibromyalgia symptoms by approximately 30 percent. LDN works through a different mechanism than standard fibromyalgia drugs, it modulates glial cell activation and reduces neuroinflammation. Typical dosing starts at 0.5 mg and titrates up to 4.5 mg at bedtime over several weeks….
